A Study of Obinutuzumab (RO5072759) Plus Chemotherapy in Comparison With Rituximab Plus Chemotherapy Followed by Obinutuzumab or Rituximab Maintenance in Patients With Untreated Advanced Indolent Non-Hodgkin's Lymphoma (GALLIUM)
about
A Study of Obinutuzumab (RO5072759) Plus Chemotherapy in Comparison With Rituximab Plus Chemotherapy Followed by Obinutuzumab or Rituximab Maintenance in Patients With Untreated Advanced Indolent Non-Hodgkin's Lymphoma (GALLIUM)
description
clinical trial
@en
klinisch onderzoek
@nl
name
A Study of Obinutuzumab (RO507 ...... n-Hodgkin's Lymphoma (GALLIUM)
@en
type
label
A Study of Obinutuzumab (RO507 ...... n-Hodgkin's Lymphoma (GALLIUM)
@en
prefLabel
A Study of Obinutuzumab (RO507 ...... n-Hodgkin's Lymphoma (GALLIUM)
@en
P17
P4844
P6153
P1050
P1132
P1476
A Multicenter, Phase III, Open ...... ntenance Therapy in Responders
@en
P17
P3098
NCT01332968
P4844
P580
2011-07-06T00:00:00Z
P582
2016-02-01T00:00:00Z